pin,drug,symptom_category,symptom,prompt
2,'bevacizumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
2,'bevacizumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
2,'bevacizumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 3 (active treatment):
EHR Context:
Age: 68 years
Gender: Male
Cancer diagnosis: Stage IV colorectal cancer with liver metastases
PMH: coronary artery disease, type 2 diabetes
Prior cancer treatments: None
Current cancer treatments: FOLFIRI + bevacizumab (started 2 months ago)
Current medication list: metformin, aspirin, atorvastatin, metoprolol, lisinopril
Summary of most recent oncology visit (6 weeks ago): 68-year-old male with newly diagnosed stage IV colorectal cancer with liver metastases. He is on first-line FOLFIRI + bevacizumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'bortezomib',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'bortezomib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'bortezomib',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'lenalidomide',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'lenalidomide', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'lenalidomide',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
6,'dexamethasone',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'dexamethasone', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
6,'dexamethasone',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 7 (active treatment):
EHR Context:
Age: 64 years
Gender: Male
Cancer diagnosis: Stage III multiple myeloma
PMH: hypertension, hyperlipidemia
Prior cancer treatments: None
Current cancer treatments: bortezomib/lenalidomide/dexamethasone (started 2 months ago)
Current medication list: lisinopril, amlodipine, simvastatin, aspirin
Summary of most recent oncology visit (4 weeks ago): 64-year-old male with newly diagnosed stage III multiple myeloma. He is on first-line bortezomib/lenalidomide/dexamethasone and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'nivolumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'nivolumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'nivolumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
7,'ipilimumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'ipilimumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
7,'ipilimumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 8 (active treatment):
EHR Context:
Age: 51 years
Gender: Female
Cancer diagnosis: Stage IIIB melanoma
PMH: hypothyroidism, osteoarthritis
Prior cancer treatments: wide local excision (completed 3 months ago)
Current cancer treatments: nivolumab/ipilimumab (started 1 month ago)
Current medication list: levothyroxine, ibuprofen, acetaminophen
Summary of most recent oncology visit (2 weeks ago): 51-year-old female with stage IIIB melanoma s/p wide local excision. She is on adjuvant nivolumab/ipilimumab and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
8,'sunitinib',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
8,'sunitinib',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: Sample 9 (active treatment):
EHR Context:
Age: 45 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: None
Prior cancer treatments: None
Current cancer treatments: sunitinib (started 2 months ago)
Current medication list: None
Summary of most recent oncology visit (4 weeks ago): 45-year-old male with newly diagnosed stage IV renal cell carcinoma. He is on first-line sunitinib and tolerating treatment well. Will continue treatment as planned.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'cisplatin',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'cisplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'cisplatin',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'paclitaxel',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'paclitaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'paclitaxel',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'bevacizumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'bevacizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'bevacizumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
48,'docetaxel',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'docetaxel', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
48,'docetaxel',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 29. Sample Given (active treatment - general chemo):
EHR Context:
Age: 42 years
Gender: Feale
Cancer diagnosis: Stage IV cervical cancer
PMH:  none
Prior cancer treatments: Cisplatin/paclitaxel/bevacizumab
Current cancer treatments: decetaxel (started 2 months ago)
Current medication list: aspirin, prochlorperazine
Summary of most recent oncology visit (1 week ago): 42 year old woman with metastatic cervical cancer, currently on second-line docetaxel She is extremely fatigued and having trouble keeping her weight up. She will come in again in 2 weeks for a symptom check, at which point we will re-evaluate her treatment plan.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
57,'pembrolizumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
57,'pembrolizumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 8. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 48 years
Gender: Male
Cancer diagnosis: Stage IIIC melanoma
PMH: None
Prior cancer treatments: Wide excision surgery followed by adjuvant immunotherapy with pembrolizumab (completed 7 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (2 months ago): 48-year-old male with a history of Stage IIIC melanoma s/p surgery and pembrolizumab immunotherapy presents for follow-up. Patient is clinically and radiographically without evidence of disease recurrence. He will be seen again in 3 months.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pembrolizumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pembrolizumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'carboplatin',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'carboplatin', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'carboplatin',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
62,'pemetrexed',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'pemetrexed', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
62,'pemetrexed',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 13. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 59 years
Gender: Female
Cancer diagnosis: Stage IV lung adenocarcinoma
PMH: None
Prior cancer treatments: Chemotherapy with carboplatin, pemetrexed, and pembrolizumab (completed 2 months ago)
Current cancer treatments: None
Current medication list: None
Summary of most recent oncology visit (1 month ago): 59-year-old female with a history of Stage IV lung cancer, currently on a treatment break, who presents for follow-up. He is doing well, and imaging showed slight disease progression.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
63,'sunitinib',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'sunitinib', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
63,'sunitinib',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: 14. Sample Given (Surveillance - specific chemo):

EHR Context:
Age: 70 years
Gender: Male
Cancer diagnosis: Stage IV renal cell carcinoma
PMH: Hypertension, diabetes
Prior cancer treatments: Nephrectomy followed by sunitinib (completed 6 months ago)
Current cancer treatments: None
Current medication list: Lisinopril, metformin, atorvastatin
Summary of most recent oncology visit (3 months ago): 70-year-old male with a history of Stage IV renal cancer s/p surgery and sunitinib presents for follow-up. Patient shows no evidence of disease.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've developed an itchy rash all over my body

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cutaneous toxicities,I've developed an itchy rash all over my body,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've developed an itchy rash all over my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cutaneous toxicities,I've noticed some new skin bumps that aren't itchy,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've noticed some new skin bumps that aren't itchy

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cutaneous toxicities,The raised patches on my skin seem to be getting worse,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: The raised patches on my skin seem to be getting worse

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cutaneous toxicities,"I'm seeing more and more flat, discolored areas on my skin","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm seeing more and more flat, discolored areas on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: The scaly patches on my skin are spreading

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cutaneous toxicities,The scaly patches on my skin are spreading,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: The scaly patches on my skin are spreading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cutaneous toxicities,I've noticed some areas where my skin color is fading,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've noticed some areas where my skin color is fading

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cutaneous toxicities,I have some fluid-filled blisters on my skin,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have some fluid-filled blisters on my skin

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I keep getting hives that won't go away

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cutaneous toxicities,I keep getting hives that won't go away,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I keep getting hives that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cutaneous toxicities,"I have a fever and a widespread rash, and my skin feels painful and is peeling","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have a fever and a widespread rash, and my skin feels painful and is peeling

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cutaneous toxicities,"My face looks swollen, especially around my eyes","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My face looks swollen, especially around my eyes

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',GI toxicities,"I've been having stomach pain, feeling nauseous, and having frequent diarrhea","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been having stomach pain, feeling nauseous, and having frequent diarrhea

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',GI toxicities,I have a fever and I've noticed blood and mucus in my stool,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have a fever and I've noticed blood and mucus in my stool

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',GI toxicities,"I've been throwing up, I don't feel like eating, and my skin and eyes look yellow","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been throwing up, I don't feel like eating, and my skin and eyes look yellow

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',GI toxicities,I have pain in my abdomen and I've noticed my urine is darker than usual,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have pain in my abdomen and I've noticed my urine is darker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',GI toxicities,"My gums bleed when I brush my teeth, which isn't normal for me","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My gums bleed when I brush my teeth, which isn't normal for me

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',GI toxicities,"I've been bruising really easily lately, even from minor bumps","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been bruising really easily lately, even from minor bumps

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've developed a cough that won't go away

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Lung toxicities,I've developed a cough that won't go away,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've developed a cough that won't go away

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Lung toxicities,"I'm feeling short of breath, even when I'm not doing much","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm feeling short of breath, even when I'm not doing much

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have pain in my chest and a fever

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Lung toxicities,I have pain in my chest and a fever,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have pain in my chest and a fever

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been having headaches and my vision seems off

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Endocrine toxicities,I've been having headaches and my vision seems off,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been having headaches and my vision seems off

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been feeling unusually cold all the time

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Endocrine toxicities,I've been feeling unusually cold all the time,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been feeling unusually cold all the time

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Endocrine toxicities,I'm exhausted all the time and I've noticed changes in my weight,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm exhausted all the time and I've noticed changes in my weight

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Endocrine toxicities,"I feel nauseous, I'm throwing up, and my stomach hurts","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I feel nauseous, I'm throwing up, and my stomach hurts

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Endocrine toxicities,I've been feeling dizzy and lightheaded,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been feeling dizzy and lightheaded

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Endocrine toxicities,I'm urinating much more frequently and I'm always thirsty,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm urinating much more frequently and I'm always thirsty

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My joints are painful and swollen

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Musculoskeletal toxicities,My joints are painful and swollen,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My joints are painful and swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Musculoskeletal toxicities,My muscles are sore and I feel weaker than usual,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My muscles are sore and I feel weaker than usual

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Musculoskeletal toxicities,The muscles in my shoulders and hips are stiff and painful,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: The muscles in my shoulders and hips are stiff and painful

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Renal toxicities,I've noticed changes in my urination and I feel bloated,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've noticed changes in my urination and I feel bloated

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have pain in my lower abdomen

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Renal toxicities,I have pain in my lower abdomen,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have pain in my lower abdomen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Renal toxicities,"I feel nauseous, I'm vomiting, and my blood pressure is high","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I feel nauseous, I'm vomiting, and my blood pressure is high

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I feel confused and not quite like myself

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Renal toxicities,I feel confused and not quite like myself,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I feel confused and not quite like myself

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Nervous system toxicities,I'm feeling weak and I'm experiencing unusual sensations in my body,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm feeling weak and I'm experiencing unusual sensations in my body

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Nervous system toxicities,I have a bad headache and I'm not thinking clearly,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I have a bad headache and I'm not thinking clearly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My vision has changed suddenly

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Nervous system toxicities,My vision has changed suddenly,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My vision has changed suddenly

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Hematologic toxicities,I've been feeling unusually tired and short of breath,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been feeling unusually tired and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Hematologic toxicities,I've noticed some unusual bruising and bleeding,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've noticed some unusual bruising and bleeding

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been having fevers and night sweats

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Hematologic toxicities,I've been having fevers and night sweats,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I've been having fevers and night sweats

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm always tired and my muscles ache

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cardiovascular toxicities,I'm always tired and my muscles ache,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I'm always tired and my muscles ache

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cardiovascular toxicities,My heart feels like it's racing and I have chest pain,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My heart feels like it's racing and I have chest pain

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I feel lightheaded and short of breath

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cardiovascular toxicities,I feel lightheaded and short of breath,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: I feel lightheaded and short of breath

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My legs and feet are swollen

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Cardiovascular toxicities,My legs and feet are swollen,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My legs and feet are swollen

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My vision is blurry and seems to be changing

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Ocular toxicities,My vision is blurry and seems to be changing,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My vision is blurry and seems to be changing

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My eyes are really sensitive to light

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Ocular toxicities,My eyes are really sensitive to light,"Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My eyes are really sensitive to light

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
92,'pembrolizumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My eyes are painful, red, and dry

Based on the patient's current use of 'pembrolizumab', how likely is it that these symptoms represent an immune-related adverse event (irAE)? Please return the corresponding number as: 1 (very unlikely), 2 (unlikely), 3 (likely), 4 (very likely)."
92,'pembrolizumab',Ocular toxicities,"My eyes are painful, red, and dry","Most recent clinic note: EHR Context:
Age: 47 years
Gender: Female
Cancer diagnosis: Stage IV malignant melanoma with lung metastases
PMH: no significant history
Prior cancer treatments: Excisional biopsy (2 years ago), targeted therapy (discontinued)
Current cancer treatments: Pembrolizumab (initiated 4 months ago)
Current medication list: loratadine, ibuprofen, acetaminophen, vitamin D
Summary of most recent oncology visit (1 month ago): 47 year old female with Stage IV malignant melanoma presents for immunotherapy management. Prior targeted therapy discontinued due to limited response. Maintaining on pembrolizumab. Imaging last month showed stable disease with no new metastases.

Patient's reported symptoms: My eyes are painful, red, and dry

Considering the patient's history and current medications, what are the top 3 most likely diagnoses causing these symptoms? Please list them in order of probability."
